A compound of the formula ##STR1## or a pharmaceutically acceptable acid addition salt thereof, in which formula the group R.sup.0 is selected from the group consisting of hydrogen, chlorine, bromine, methyl, trifluoromethyl and methoxy. Pharmaceutical compositions containing these compounds are useful for treatment of depressive disorders.
本发明涉及一种化合物,其
化学式为##STR1##或其药学上可接受的酸盐,其中R.sup.0基团选择自氢、
氯、
溴、甲基、三
氟甲基和甲氧基的群。含有这些化合物的药物组合物可用于治疗抑郁症。